About Epirium Bio
Epirium Bio is a company based in San Diego (United States) founded in 2008.. Epirium Bio has raised $85 million across 1 funding round from investors including Arch Venture Partners, Longitude Capital and Adams Street Partners. Epirium Bio offers products and services including EPM-01 and MF-300. Epirium Bio operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$85 M (USD)
in 1 rounds
-
Latest Funding Round
$85 M (USD), Series A
Dec 18, 2019
-
Investors
Arch Venture Partners
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epirium Bio
Epirium Bio offers a comprehensive portfolio of products and services, including EPM-01 and MF-300. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral synthetic compound targeting mitochondrial dysfunction in muscular dystrophy.
Small molecule aimed at improving function in sarcopenia and related conditions.
Unlock access to complete
Unlock access to complete
Funding Insights of Epirium Bio
Epirium Bio has successfully raised a total of $85M through 1 strategic funding round. The most recent funding activity was a Series A round of $85 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $85.0M
-
First Round
First Round
(18 Dec 2019)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series A - Epirium Bio | Valuation | Longitude Capital , Arch Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Epirium Bio
Epirium Bio has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Arch Venture Partners, Longitude Capital and Adams Street Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Private markets investment management with strategies in equity, credit, and secondary investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Epirium Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Epirium Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epirium Bio Comparisons
Competitors of Epirium Bio
Epirium Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epirium Bio
Frequently Asked Questions about Epirium Bio
When was Epirium Bio founded?
Epirium Bio was founded in 2008 and raised its 1st funding round 11 years after it was founded.
Where is Epirium Bio located?
Epirium Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Epirium Bio?
Russell J Cox is the current CEO of Epirium Bio.
Is Epirium Bio a funded company?
Epirium Bio is a funded company, having raised a total of $85M across 1 funding round to date. The company's 1st funding round was a Series A of $85M, raised on Dec 18, 2019.
What does Epirium Bio do?
Founded in 2008 in San Diego, United States, Epirium Bio operates within the biotechnology sector. Viral immunotherapies are developed to promote mitochondrial biogenesis and function among cancer patients. An IP-protected platform of small molecules has been established, forming a new class of therapeutics designed to stimulate mitochondrial activity. Operations center on advancing these treatments for oncology applications.
Who are the top competitors of Epirium Bio?
Epirium Bio's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Epirium Bio offer?
Epirium Bio offers EPM-01 and MF-300.
Who are Epirium Bio's investors?
Epirium Bio has 6 investors. Key investors include Arch Venture Partners, Longitude Capital, Adams Street Partners, The Longevity Fund, and Bluebird Ventures.